Eledon Pharmaceuticals (ELDN) Other Non Operating Income (2014 - 2026)
Eledon Pharmaceuticals (ELDN) posted Other Non Operating Income of $1.1 million for Q1 2026, up 6.78% on a QoQ basis from $1.0 million in Q3 2025, and down 20.65% year-over-year from $1.4 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) Other Non Operating Income (2014 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Other Non Operating Income history runs 12 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Other Non Operating Income fell 20.65% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 31.31% YoY) and the FY2024 annual result came in at $2.8 million, up 190.02% from the prior year.
- Other Non Operating Income was $1.1 million for Q1 2026 at Eledon Pharmaceuticals, up from $1.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.4 million in Q1 2025 and bottomed at -$990000.0 in Q4 2023.
- A 5-year average of $565687.5 and a median of $674500.0 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 6860.0% in 2023, while the deepest fall reached 425.66% in 2023.
- Eledon Pharmaceuticals' Other Non Operating Income stood at $304000.0 in 2022, then sank by 425.66% to -$990000.0 in 2023, then soared by 133.74% to $334000.0 in 2024, then surged by 213.47% to $1.0 million in 2025, then gained by 6.78% to $1.1 million in 2026.
- Business Quant data shows ELDN's Other Non Operating Income at $1.1 million in Q1 2026, $1.0 million in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 334,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 869,000.00 |
| Mar 31, 2024 | 574,000.00 |
| Dec 31, 2023 | -990,000.00 |
| Sep 30, 2023 | 849,000.00 |
| Jun 30, 2023 | 775,000.00 |
| Mar 31, 2023 | 338,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 36,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | 644,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 5,000.00 |